Sigal Kaplan, PhD, BPharm
Teva Pharmaceutical Industries Ltd., Netanya, Israel
- 1Article
- 1.5KReads1
- 2026Active
- 7Collaborators
1 Read counts for articles published before 2020 may include some non-human traffic.
About
Sigal Kaplan, PhD, BPharm is affiliated with Teva Pharmaceutical Industries Ltd., Netanya, Israel. Sigal Kaplan has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2026. Their work focuses on Bipolar Disorder.
Publications
Outcomes and Practice Patterns of LAI Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the US
March 2, 2026
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.